In contrast, treatment with digitoxin plus MEK inhibitor significantly reduced NHE activity in both melanomas compared with control mice and mice treated with digitoxin or MEK inhibitor alone (Fig. 4d). The gene discussed is MAP2K7; the disease is melanoma.